Merck & Co., Inc.Kenilworth, New Jersey, United States
Disclosure(s): Merck & Co., Inc.: Employee, Stocks/Bonds (Public Company)
539 - Clesrovimab Binding Site Conservation on the RSV F Protein: An Evaluation of RSV Molecular Sequencing Data from 2019-2023 and GenBank Sequence Analysis
Saturday, October 19, 202412:25 PM – 12:30 PM US PT